Clarius Group LLC Has $523,000 Stock Holdings in HCA Healthcare, Inc. (NYSE:HCA)

Clarius Group LLC decreased its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 2.5% in the 3rd quarter, HoldingsChannel reports. The firm owned 1,293 shares of the company’s stock after selling 33 shares during the period. Clarius Group LLC’s holdings in HCA Healthcare were worth $523,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors also recently modified their holdings of the company. CreativeOne Wealth LLC acquired a new stake in shares of HCA Healthcare during the first quarter worth $231,000. New Mexico Educational Retirement Board lifted its holdings in shares of HCA Healthcare by 29.9% during the first quarter. New Mexico Educational Retirement Board now owns 13,900 shares of the company’s stock worth $4,636,000 after buying an additional 3,200 shares in the last quarter. Kingswood Wealth Advisors LLC acquired a new stake in shares of HCA Healthcare during the first quarter worth $566,000. Teachers Retirement System of The State of Kentucky raised its stake in HCA Healthcare by 15.6% in the fourth quarter. Teachers Retirement System of The State of Kentucky now owns 199,209 shares of the company’s stock valued at $53,922,000 after purchasing an additional 26,919 shares in the last quarter. Finally, Bessemer Group Inc. raised its stake in HCA Healthcare by 51.2% in the first quarter. Bessemer Group Inc. now owns 7,629 shares of the company’s stock valued at $2,543,000 after purchasing an additional 2,584 shares in the last quarter. Institutional investors and hedge funds own 62.73% of the company’s stock.

Insider Buying and Selling at HCA Healthcare

In other HCA Healthcare news, SVP Kathryn A. Torres sold 1,857 shares of the business’s stock in a transaction that occurred on Thursday, July 25th. The stock was sold at an average price of $355.05, for a total value of $659,327.85. Following the transaction, the senior vice president now directly owns 17,755 shares of the company’s stock, valued at approximately $6,303,912.75. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other news, SVP Christopher F. Wyatt sold 4,000 shares of the company’s stock in a transaction that occurred on Monday, July 29th. The stock was sold at an average price of $360.20, for a total transaction of $1,440,800.00. Following the transaction, the senior vice president now directly owns 40,449 shares of the company’s stock, valued at $14,569,729.80. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, SVP Kathryn A. Torres sold 1,857 shares of the company’s stock in a transaction that occurred on Thursday, July 25th. The stock was sold at an average price of $355.05, for a total value of $659,327.85. Following the transaction, the senior vice president now directly owns 17,755 shares in the company, valued at $6,303,912.75. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 17,202 shares of company stock valued at $6,407,273. 1.60% of the stock is currently owned by company insiders.

Analyst Ratings Changes

A number of research firms recently commented on HCA. Truist Financial boosted their price target on HCA Healthcare from $390.00 to $430.00 and gave the company a “buy” rating in a research note on Monday, August 19th. Morgan Stanley began coverage on HCA Healthcare in a research note on Tuesday, September 3rd. They issued an “equal weight” rating and a $427.00 price target for the company. Deutsche Bank Aktiengesellschaft boosted their price target on HCA Healthcare from $359.00 to $375.00 and gave the company a “buy” rating in a research note on Friday, June 28th. Leerink Partners lifted their target price on HCA Healthcare from $367.00 to $396.00 and gave the company an “outperform” rating in a research report on Wednesday, July 24th. Finally, Cantor Fitzgerald reiterated an “overweight” rating and issued a $392.00 target price on shares of HCA Healthcare in a research report on Tuesday, October 1st. Five analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and three have given a strong buy rating to the stock. According to MarketBeat.com, HCA Healthcare currently has an average rating of “Moderate Buy” and a consensus target price of $365.65.

HCA Healthcare Stock Performance

NYSE:HCA opened at $394.54 on Friday. The stock’s 50-day moving average is $387.15 and its 200-day moving average is $347.49. The company has a current ratio of 1.06, a quick ratio of 0.94 and a debt-to-equity ratio of 27.11. The stock has a market cap of $101.82 billion, a P/E ratio of 18.52, a price-to-earnings-growth ratio of 1.44 and a beta of 1.67. HCA Healthcare, Inc. has a 1-year low of $215.96 and a 1-year high of $409.42.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings data on Tuesday, July 23rd. The company reported $5.50 EPS for the quarter, topping analysts’ consensus estimates of $4.97 by $0.53. The company had revenue of $17.49 billion for the quarter, compared to analyst estimates of $17.05 billion. HCA Healthcare had a return on equity of 553.13% and a net margin of 8.40%. The firm’s quarterly revenue was up 10.3% on a year-over-year basis. During the same period in the previous year, the firm earned $4.29 earnings per share. Equities research analysts anticipate that HCA Healthcare, Inc. will post 22.51 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Monday, September 30th. Shareholders of record on Monday, September 16th were paid a $0.66 dividend. This represents a $2.64 annualized dividend and a yield of 0.67%. The ex-dividend date was Monday, September 16th. HCA Healthcare’s dividend payout ratio (DPR) is presently 12.39%.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.